Academic Board

John DR Jolley

Is a Pharmaceutical Consultant providing technical consultancy and bespoke training solutions to the Pharmaceutical Profession, he has a degree in Pharmacy and has been awarded fellowships with the Royal Pharmaceutical Society and Chartered Quality Institute as a consultant lead assessor.

He obtained a BSc Pharm Hons degree in Pharmacy, and a research fellowship at Boots research Nottingham working on formulation development, during which time he published several technical papers.

He joined Beecham Products UK as a management Trainee and was later appointed General Manager of a Beecham subsidiary in Ireland, returning to Beecham Head Quarters in London, where he worked as special products adviser to the Divisional Managing Director for Beecham Products.

He was invited to join Boehringer Ingelheim (UK) Ltd as Technical Director and remained there for 15 years before leaving to establish “Pharma Consult” an International technical and training consultancy working with associates in the US- Latin America- Asia Specific, Saudi Arabia and Other GCC countries, and India.

He have held positions with responsibility for; Clinical Research, Product Registration, Manufacturing, Distribution, Quality Assurance, and General Management

He was awarded Fellowship with the Royal Pharmaceutical Society (UK) and in 2003 was elected to serve on the council of the RPS(UK) as their treasurer. In 1998 I became Consultant Lead assessor of the Chartered Quality Institute and in 2015 was invited to join the worshipful Society of Apothecaries and granted the freedom of the City of London.

Steve Jolley

Steve Jolley is a subject matter expert in all areas of global safety compliance and signal detection, and is a frequent speaker at leading industry events.

Steve has 35 years’ experience in drug safety & pharmacovigilance and has worked with over 250 clients in North America, Europe, Japan, India, China, the Middle East and Africa. He holds degrees in mathematics and computer science from Cambridge University, England. He is an Adjunct Professor at Rutgers University and teaches part of their Master's degree in Drug Safety and Pharmacovigilance.

Steve is a featured speaker with FDA, EMA and MHRA at conferences and webinars on auditing, signaling and data mining.  He is a member of DIA’s training faculty and is an instructor for DIA’s Clinical Safety and Pharmacovigilance Certificate Program.  In 2010 Steve was elected as chairman of the DIA’s Clinical Safety and Pharmacovigilance steering committee for North America. 

Steve began his career in the pharmaceutical industry in 1985 when he founded DLB Systems, a supplier of computer systems for clinical trials and adverse event reporting to many of the leading life science companies worldwide.  DLB was acquired by eResearch Technologies in 1997; since then Steve has worked as an independent consultant.

Ravi Joshi

Ravi is a former Managing Director at PharmEng Technology, Managing Director Trillium Technologies Group Inc., Executive VP PharmEng International, who was also on the Board of Director of the publicly traded company.

He brings vast multinational experience as a Director Pharma Development Novartis Canada, Director Technical Services Sandoz Canada and Associate Director Production Sandoz Canada, Manager Quality Services, Sandoz Canada, Production Manager Sandoz Canada.

His international experience was gained as a Production Manager Boots Drug Company Kenya.

Ravi Joshi brings over 30 years of North American leadership experience in Management of Consulting practice, and hands-on experience in recruiting technical staff in Quality Systems, Product Development, GMP and Technical Audits, Commissioning and Validation activities in the pharmaceutical and biotechnology sectors.

Mr. Joshi holds extensive expertise in pharmaceutical solid, semi solid and liquid dosage formulation, process development and process validation. He is an expert in conceptual design for sterile and non-sterile manufacturing, filling and packaging operations in pharmaceutical and biotechnology sectors. He is an innovative strategist, skilled at assessing and implementing cost effective solutions with ability to deliver efficient training and team building.

Mr. Joshi's business acumen and unique perspective have provided effective solutions to all clients.